AGIO

AGIO

USD

Agios Pharmaceuticals Inc. Common Stock

$39.440+0.110 (0.280%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$39.330

Haut

$40.320

Bas

$38.900

Volume

0.19M

Fondamentaux de l'Entreprise

Capitalisation Boursière

2.3B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.65M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $23.42Actuel $39.440Haut $62.58

Actualités Connexes

GlobeNewswire

Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases,

Voir plus
Agios to Present New Mitapivat Data in Rare Blood Disorders at 67th ASH Annual Meeting and Exposition
GlobeNewswire

Agios Reports Third Quarter 2025 Financial Results and Provides Business Update

$12.9 million in third quarter PYRUKYND® (mitapivat) net revenuesPDUFA goal date for PYRUKYND U.S. sNDA in thalassemia set for December 7, 2025CHMP adopted positive opinion for PYRUKYND in thalassemia; EC decision

Voir plus
Agios Reports Third Quarter 2025 Financial Results and Provides Business Update

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.